Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBeximco Pharma Regulatory News (BXP)

Share Price Information for Beximco Pharma (BXP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.50
Bid: 37.00
Ask: 40.00
Change: -1.50 (-3.75%)
Spread: 3.00 (8.108%)
Open: 40.00
High: 40.00
Low: 38.50
Prev. Close: 40.00
BXP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Detention of Salman Rahman

12 Feb 2007 15:51

Beximco Pharmaceuticals Ltd12 February 2007 BEXIMCO PHARMACEUTICALS LTD. Detention of Salman Rahman Beximco Pharmaceuticals Ltd. (the "Company") announces that Mr. Salman Rahman,Vice-Chairman of the Company was put under preventive detention under theSpecial Powers Act on 5 February 2007. This was subsequent to the declaration ofthe State of Emergency in Bangladesh on 11 January 2007, following postponementof the general election. Under the Special Powers Act, it is possible to bedetained without the accusation of any offence. Mr. Rahman served as Adviser for Private Sector Affairs to the then leader ofthe opposition Sheikh Hasina, President of Bangladesh Awami League, by virtue ofwhich, he is considered an important political personality in Bangladesh. The Company can confirm that no formal charges have been brought against Mr.Rahman and the reasons for his detention have not been given by the authorities.It is understood that over 25,000 people nationally, including political partyleaders and prominent businessmen, have been detained as part of this action. The detention has not in any way affected the operating performance of theCompany which continues to meet management expectations. Further announcements will be made as information becomes available. The resultsfor the year ending 31 December 2006 will be announced at the end of April 2007. For further enquiries please contact: Beximco PharmaNazmul Hassan, CEOTel: +880 2 861 9151, ext.2080 Libertas CapitalAamir QuraishiTel: +44 (0)20 7569 9650 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Dec 20187:00 amRNSEGM Statement
30th Nov 20187:00 amRNSAGM Notification
30th Nov 20187:00 amRNSEGM Notification
29th Nov 20188:30 amRNSBeximco Pharma wins at Scrip Awards 2018
14th Nov 20187:00 amRNSResults for First Quarter Ended 30 September 2018
7th Nov 20187:00 amRNSResults for the 12 month period ended 30 June 2018
26th Oct 20187:00 amRNSNotification of Preliminary Results and AGM
30th Jul 20187:00 amRNSUS FDA Approves Beximco Pharma's Nadolol Tablets
23rd Jul 20187:00 amRNSCommences export of fourth product to the US
27th Apr 20187:00 amRNS3rd Quarter Results
23rd Apr 20187:00 amRNSCommences Export of Third Product to the US Market
3rd Apr 20187:00 amRNSCompletion of the Acquisition of Nuvista Pharma
30th Jan 20187:00 amRNSHalf Year Results 2017-18
19th Jan 20187:00 amRNSPayment of Cash Dividend
19th Jan 20187:00 amRNSAcquisition of a Majority Stake in Nuvista Pharma
27th Dec 20177:00 amRNSAGM Statement
30th Nov 201710:30 amRNSBeximco Pharma wins at Scrip Awards 2017
23rd Nov 201711:53 amRNSNotice of AGM
14th Nov 20177:00 amRNSResults for First Quarter Ended 30 September 2017
7th Nov 20177:00 amRNSCommencement of Second Product Export to the US
6th Nov 201710:30 amRNSResults for the 12 month period ended 30 June 2017
26th Oct 20177:00 amRNSNotice of Preliminary Results and AGM
6th Oct 20177:00 amRNSSigns a Non-Binding MoU with Nuvista Pharma
2nd Oct 20177:00 amRNSChange of Broker
18th Sep 20177:00 amRNSCommences Export to Canada
25th Jul 20177:00 amRNSFDA approves Beximco Pharma Methocarbamol tablets
28th Apr 20177:00 amRNSFinancial Results for the Third Quarter of 2016-17
27th Jan 20177:00 amRNSHalf year results 2016-17
25th Jan 20177:00 amRNSBeximco Pharma forms JV with BioCare Manufacturing
19th Dec 20167:00 amRNSUS FDA approves Metformin for diabetes control
16th Dec 201610:12 amRNSPayment of Cash Dividend
12th Dec 20161:54 pmRNSStock Dividend Issued and Total Voting Rights
21st Nov 20167:00 amRNSAGM Statement
15th Nov 20167:00 amRNS1st Quarter Results
25th Oct 20167:00 amRNSReceives second product approval from the US FDA
20th Oct 20167:00 amRNSResults for the 18 month period ended 30 June 2016
19th Oct 20167:00 amRNSNotice of AGM
7th Oct 20167:00 amRNSNotification of Preliminary Results and AGM
5th Aug 20167:00 amRNSBeximco Pharma commences export to the US
17th Jun 20167:00 amRNSBeximco Pharma commences export to Kuwait
9th May 20167:00 amRNSFinal Results
6th May 20167:01 amRNSAGM Change and Dividend Update
6th May 20167:00 amRNSChange of Accounting Reference Date
4th May 20167:00 amRNSAmendment to Notification of Preliminary Results
21st Apr 20167:00 amRNSNotification of Preliminary Results and AGM
19th Nov 20157:00 amRNSUS FDA approval to manufacture blood pressure drug
27th Oct 20157:00 amRNS3rd Quarter Results
24th Jul 20157:00 amRNSHalf Yearly Report
13th Jul 201510:53 amRNSPayment of Cash Dividend
26th Jun 20157:00 amRNSStock Dividend Issued and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.